FI962749A - Uusia heterosyklisiä yhdisteitä - Google Patents

Uusia heterosyklisiä yhdisteitä Download PDF

Info

Publication number: FI962749A
Authority: FI; Finland
Prior art keywords: heterocyclic compounds; new heterocyclic; substituted; hyperalgesic; painful
Prior art date: 1994-01-04

Application number

FI962749A

Other languages

English (en)

Swedish (sv)

Other versions

FI114025B (fi

FI962749A0 (fi

Inventor

Knud Erik Andersen

Uffe Bang Olsen

Hans Petersen

Frederik Christian Groenvald

Ursula Sonnewald

Tine Krogh Joergensen

Henrik Sune Andersen

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-01-04

Filing date

1996-07-04

Publication date

1996-09-04

1996-07-04 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1996-07-04 Publication of FI962749A0 publication Critical patent/FI962749A0/fi

1996-09-04 Publication of FI962749A publication Critical patent/FI962749A/fi

2004-07-30 Application granted granted Critical

2004-07-30 Publication of FI114025B publication Critical patent/FI114025B/fi

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Anesthesiology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Indole Compounds (AREA)

FI962749A 1994-01-04 1996-07-04 Uudet heterosykliset yhdisteet FI114025B (fi)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
DK1994		1994-01-04
DK1994		1994-01-04
DK129094		1994-11-09
DK129094		1994-11-09
PCT/DK1995/000002 WO1995018793A1 (en)	1994-01-04	1995-01-03	Novel heterocyclic compounds
DK9500002		1995-01-03

Publications (3)

Publication Number	Publication Date
FI962749A0 FI962749A0 (fi)	1996-07-04
FI962749A true FI962749A (fi)	1996-09-04
FI114025B FI114025B (fi)	2004-07-30

Family

ID=26063135

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI962749A FI114025B (fi)	1994-01-04	1996-07-04	Uudet heterosykliset yhdisteet

Country Status (31)

Country	Link
US (8)	US5595989A (fi)
EP (1)	EP0738262B1 (fi)
JP (1)	JP2944221B2 (fi)
KR (1)	KR100329450B1 (fi)
CN (1)	CN1083431C (fi)
AT (1)	ATE191909T1 (fi)
AU (1)	AU691858B2 (fi)
BG (1)	BG100692A (fi)
BR (1)	BR9506452A (fi)
CA (1)	CA2180238A1 (fi)
CZ (1)	CZ286109B6 (fi)
DE (1)	DE69516394T2 (fi)
DK (1)	DK0738262T3 (fi)
ES (1)	ES2147837T3 (fi)
FI (1)	FI114025B (fi)
GR (1)	GR3033967T3 (fi)
HU (1)	HUT75878A (fi)
IL (1)	IL112222A (fi)
MY (1)	MY113463A (fi)
NO (1)	NO306295B1 (fi)
NZ (1)	NZ277763A (fi)
PE (1)	PE45095A1 (fi)
PL (1)	PL180209B1 (fi)
PT (1)	PT738262E (fi)
RU (1)	RU2167152C2 (fi)
SG (1)	SG50602A1 (fi)
SI (1)	SI9520023A (fi)
SK (1)	SK88196A3 (fi)
TW (1)	TW300887B (fi)
UA (1)	UA47396C2 (fi)
WO (1)	WO1995018793A1 (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6110913A (en) *	1994-01-04	2000-08-29	Novo Nordisk A/S	N-substituted azaheterocyclic carboxylic acids and esters thereof
US6239148B1 (en) *	1994-01-04	2001-05-29	Novo Nordisk A/S	N-substituted azaheterocyclic carboxylic acids and esters thereof
MY113463A (en) *	1994-01-04	2002-03-30	Novo Nordisk As	Novel heterocyclic compounds
US5952352A (en) *	1995-04-07	1999-09-14	Novo Nordisk A/S	Heterocyclic compounds
US5962449A (en)	1995-04-07	1999-10-05	Novo Nordisk A/S	Tricyclic compounds in treating hyperalgesic conditions and NIDDM
UA54385C2 (uk) *	1995-04-07	2003-03-17	Ново Нордіск А/С	N-заміщені азагетероциклічні карбонові кислоти та їх ефіри, спосіб їх одержання, фармацевтична композиція та спосіб лікування
US5716949A (en) *	1995-04-07	1998-02-10	Novo Nordisk A/S	Heterocyclic compounds
US5698551A (en) *	1995-04-07	1997-12-16	Novo Nordisk A/S	Heterocyclic compounds
IL124557A0 (en) *	1995-12-15	1998-12-06	Novo Nordisk As	Compositions for reducing blood glucose and/or inhibiting the activity of cgrp
US6323206B1 (en)	1996-07-12	2001-11-27	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
ZA978792B (en) *	1996-10-04	1998-04-06	Novo Nordisk As	N-substituted azaheterocyclic compounds.
BR9712196A (pt) *	1996-10-04	1999-08-31	Novo Nordisk As	Composto, uso do mesmo, processo para sua preparação e para tratar inflamação neurogênica, e, composições farmacêuticas para tratar inflamação neurogênica, para tratar neuropatia, para tratar artrite reumatóide, para reduzir glicose no sangue e/ou para inibir a atividade de cgrp, para tratar enxaqueca e para tratar coceira
WO1998015546A1 (en) *	1996-10-04	1998-04-16	Novo Nordisk A/S	N-substituted azaheterocyclic compounds
US6040318A (en) *	1997-06-25	2000-03-21	Novo Nordisk A/S	Tricycle substituted with azaheterocyclic carboxylic acids
US6054453A (en)	1997-10-27	2000-04-25	Redd's Research Foundation	Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
DE69928226T8 (de)	1998-01-21	2006-10-19	Millennium Pharmaceuticals, Inc., Cambridge	Chemokin rezeptor antagonisten und verwendung
EP1047675A1 (en) *	1998-01-21	2000-11-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en)	1998-01-21	2003-01-21	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en)	1998-01-21	2003-09-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) *	1998-09-04	2007-09-18	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use thereof
US6468996B1 (en) *	1998-10-21	2002-10-22	Novo Nordisk A/S	Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
US6207682B1 (en)	1998-12-22	2001-03-27	Novo Nordisk A/S	Modified release formulations containing (R)-1-(10,11-dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1propyl)-3-piperidinecarboxylic acid
EP1140084A1 (en) *	1998-12-22	2001-10-10	Novo Nordisk A/S	Novel formulation
US7355042B2 (en) *	2001-10-16	2008-04-08	Hypnion, Inc.	Treatment of CNS disorders using CNS target modulators
US7541365B2 (en)	2001-11-21	2009-06-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US20040087642A1 (en) *	2002-10-24	2004-05-06	Zeldis Jerome B.	Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
TWI291467B (en) *	2002-11-13	2007-12-21	Millennium Pharm Inc	CCR1 antagonists and methods of use therefor
US20070066570A1 (en) *	2003-06-16	2007-03-22	Michael Solomon	Methods for treating sleep disorders
JP2010502621A (ja)	2006-09-01	2010-01-28	イミユーン・コントロール・インコーポレーテツド	リンパ球の活性化に関連した病気を治療するための新規な組成物および方法
TW201711999A (zh)	2015-09-03	2017-04-01	佛瑪治療公司	﹝６，６﹞稠合雙環組蛋白脫乙醯基酶８（ｈｄａｃ８）抑制劑
CA3069699A1 (en)	2017-07-13	2019-01-17	Tonix Pharmaceuticals Holding Corp.	Analogs of cyclobenzaprine and amitryptilene
CN115850232B (zh) *	2023-02-16	2023-05-26	广州佳途科技股份有限公司	一种氟哌噻吨ep杂质h的制备方法及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2931810A (en) *		1960-04-05		Phenothiazine derivatives
US3316249A (en) *		1967-04-25		Part a.xmethyl n n-(z-diethylaminoethyl)-n-(z- nitrophenyl) anthranilate hydrochloride
BE552557A (fi) *	1955-11-15
NL108827C (fi) *	1956-04-09
NL99690C (fi) *	1956-11-15
BE560750A (fi) *	1957-07-26
NL222355A (fi) *	1957-11-05
FR1216268A (fr) *	1958-04-24	1960-04-25	Rhone Poulenc Sa	Nouveaux dérivés de la phénothiazine à chaîne pipéridine substituée par une fonction amide et leur préparation
US3069432A (en) *	1961-02-20	1962-12-18	Olin Mathieson	5-(aminoalkyl)-5, 11-dihydrodibenzo-oxazepines
DE1159954B (de) *	1961-11-25	1963-12-27	Boehringer & Soehne Gmbh	Verfahren zur Herstellung neuer 10-(Alkoxypiperidinopropyl)-phenthiazine und ihrer Salze
US3157658A (en) *	1963-07-05	1964-11-17	Searle & Co	1-carbalkoxy-4-(9-xanthenyl) piperazines and related compounds
FR145F (fi) *	1964-06-01
US3886170A (en) *	1974-04-22	1975-05-27	Robins Co Inc A H	5-(3-)SUBSTITUTED-10,11-DIHYDRO-5H-dibenz{8 b,f{9 azepines
US4888335A (en) *	1988-07-25	1989-12-19	Mcneilab, Inc.	3-alkoxy-2-aminopropyl heterocyclic amines and their use as cardiovascular agents
US5296602A (en) *	1991-03-18	1994-03-22	Sloan-Kettering Institute For Cancer Research	Multisubstituted 1-hydroxy-9-acridones with anticancer activity
US5420123A (en) *	1992-12-21	1995-05-30	Bristol-Myers Squibb Company	Dibenzodiazepine endothelin antagonists
US5538986A (en) *	1993-12-06	1996-07-23	Schering Corporation	Tricyclic derivatives, compositions and methods of use
MY113463A (en) *	1994-01-04	2002-03-30	Novo Nordisk As	Novel heterocyclic compounds

1994
- 1994-12-30 MY MYPI94003583A patent/MY113463A/en unknown
1995
- 1995-01-02 IL IL11222295A patent/IL112222A/xx not_active IP Right Cessation
- 1995-01-03 KR KR1019960703605A patent/KR100329450B1/ko not_active IP Right Cessation
- 1995-01-03 ES ES95904409T patent/ES2147837T3/es not_active Expired - Lifetime
- 1995-01-03 NZ NZ277763A patent/NZ277763A/en unknown
- 1995-01-03 AT AT95904409T patent/ATE191909T1/de not_active IP Right Cessation
- 1995-01-03 US US08/367,648 patent/US5595989A/en not_active Expired - Fee Related
- 1995-01-03 EP EP95904409A patent/EP0738262B1/en not_active Expired - Lifetime
- 1995-01-03 JP JP7518275A patent/JP2944221B2/ja not_active Expired - Fee Related
- 1995-01-03 WO PCT/DK1995/000002 patent/WO1995018793A1/en active IP Right Grant
- 1995-01-03 CN CN95191845A patent/CN1083431C/zh not_active Expired - Fee Related
- 1995-01-03 SI SI9520023A patent/SI9520023A/sl unknown
- 1995-01-03 DE DE69516394T patent/DE69516394T2/de not_active Expired - Fee Related
- 1995-01-03 HU HU9601842A patent/HUT75878A/hu unknown
- 1995-01-03 DK DK95904409T patent/DK0738262T3/da active
- 1995-01-03 AU AU13110/95A patent/AU691858B2/en not_active Ceased
- 1995-01-03 RU RU96116134/04A patent/RU2167152C2/ru not_active IP Right Cessation
- 1995-01-03 PT PT95904409T patent/PT738262E/pt unknown
- 1995-01-03 UA UA96072659A patent/UA47396C2/uk unknown
- 1995-01-03 SK SK881-96A patent/SK88196A3/sk unknown
- 1995-01-03 CZ CZ19961921A patent/CZ286109B6/cs unknown
- 1995-01-03 SG SG1996006195A patent/SG50602A1/en unknown
- 1995-01-03 CA CA002180238A patent/CA2180238A1/en not_active Abandoned
- 1995-01-03 PL PL95315294A patent/PL180209B1/pl not_active IP Right Cessation
- 1995-01-03 BR BR9506452A patent/BR9506452A/pt not_active IP Right Cessation
- 1995-01-04 PE PE1995258527A patent/PE45095A1/es not_active Application Discontinuation
- 1995-02-22 TW TW084101613A patent/TW300887B/zh active
- 1995-05-18 US US08/444,140 patent/US5688788A/en not_active Expired - Fee Related
- 1995-10-18 US US08/544,905 patent/US5712292A/en not_active Expired - Fee Related
- 1995-10-18 US US08/544,500 patent/US5721254A/en not_active Expired - Fee Related
- 1995-10-18 US US08/544,682 patent/US5795888A/en not_active Expired - Fee Related
- 1995-10-18 US US08/544,502 patent/US5693649A/en not_active Expired - Fee Related
1996
- 1996-03-27 US US08/626,745 patent/US5668129A/en not_active Expired - Fee Related
- 1996-07-02 BG BG100692A patent/BG100692A/xx unknown
- 1996-07-03 NO NO962811A patent/NO306295B1/no not_active IP Right Cessation
- 1996-07-04 FI FI962749A patent/FI114025B/fi active
1998
- 1998-01-23 US US09/012,918 patent/US6043239A/en not_active Expired - Fee Related
2000
- 2000-07-17 GR GR20000401652T patent/GR3033967T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
US5795888A (en)	1998-08-18
AU691858B2 (en)	1998-05-28
CA2180238A1 (en)	1995-07-13
SG50602A1 (en)	1998-07-20
US6043239A (en)	2000-03-28
SK88196A3 (en)	1997-06-04
PL180209B1 (pl)	2001-01-31
FI114025B (fi)	2004-07-30
IL112222A0 (en)	1995-03-30
US5693649A (en)	1997-12-02
IL112222A (en)	1999-12-31
CN1083431C (zh)	2002-04-24
BR9506452A (pt)	1997-09-02
DE69516394D1 (de)	2000-05-25
EP0738262B1 (en)	2000-04-19
TW300887B (fi)	1997-03-21
FI962749A0 (fi)	1996-07-04
KR100329450B1 (ko)	2002-10-04
CZ286109B6 (cs)	2000-01-12
CZ192196A3 (en)	1997-05-14
NZ277763A (en)	2001-11-30
GR3033967T3 (en)	2000-11-30
NO962811D0 (no)	1996-07-03
US5668129A (en)	1997-09-16
PT738262E (pt)	2000-10-31
ATE191909T1 (de)	2000-05-15
NO306295B1 (no)	1999-10-18
US5688788A (en)	1997-11-18
PE45095A1 (es)	1995-12-18
DK0738262T3 (da)	2000-09-04
AU1311095A (en)	1995-08-01
HU9601842D0 (en)	1996-09-30
MY113463A (en)	2002-03-30
BG100692A (en)	1997-09-30
CN1142226A (zh)	1997-02-05
JP2944221B2 (ja)	1999-08-30
WO1995018793A1 (en)	1995-07-13
ES2147837T3 (es)	2000-10-01
US5595989A (en)	1997-01-21
JPH09507239A (ja)	1997-07-22
DE69516394T2 (de)	2000-10-26
EP0738262A1 (en)	1996-10-23
US5721254A (en)	1998-02-24
US5712292A (en)	1998-01-27
NO962811L (no)	1996-09-04
UA47396C2 (uk)	2002-07-15
HUT75878A (en)	1997-05-28
RU2167152C2 (ru)	2001-05-20
SI9520023A (en)	1997-04-30

Publication	Publication Date	Title
FI962749A (fi)	1996-09-04	Uusia heterosyklisiä yhdisteitä
MX9707531A (es)	1997-11-29	Nuevos compuestos heterociclicos.
EA200400944A1 (ru)	2005-04-28	Замещенные производные тетрациклина, фармацевтическая композиция и способ лечения субъекта с их использованием
EA200201271A1 (ru)	2003-04-24	Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
FI956119A0 (fi)	1995-12-19	Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina
PE59099A1 (es)	1999-06-21	Nuevos derivados del acido hexanoico
PT1041072E (pt)	2003-11-28	Acidos dioxociclopentil hidroxamicos
DE69615169D1 (de)	2001-10-18	N-substituierte azaheterocyclische Carbonsäuren und ihre Alkylester
ES2173858T3 (es)	2002-11-01	Analogos de huperzina a.
DE3763863D1 (de)	1990-08-30	Substituierte tetrahydro-3-pyridincarbonsaeuren, ihre ester und amide als cholinergische mittel.
BR0109328A (pt)	2003-06-10	Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica
AU5100496A (en)	1996-10-23	Novel heterocyclic compounds
EA199800701A1 (ru)	1999-02-25	БЕНЗО[С]ХИНОЛИЗИНОВЫЕ ПРОИЗВОДНЫЕ, ИХ ПОЛУЧЕНИЕ И ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ 5a-РЕДУКТАЗ
AR043186A1 (es)	2005-07-20	Indozolamidas dotadas de actividad analgesica, metodo de preparacion de las mismas y compuesto farmaceutico que las comprende
IL117812A0 (en)	1996-08-04	N-substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
HUP0203118A2 (hu)	2003-01-28	Béta-diszubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
UY28618A1 (es)	2005-06-30	Nuevos indoles sustituidos de piperidina o heteroderivados de los mismos
HUP0000307A2 (hu)	2000-12-28	Y Neuropeptid antagonisták és ezeket tartalmazó gyógyászati készítmények
ATE157086T1 (de)	1997-09-15	N-substituierte azaheterozyklische carbonsäuren und pharmazeutische zusammensetzung